

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective st...
Q2 2026
Aug 13, 2026
Q1 2026
May 12, 2026
FY 2025
Mar 6, 2026
Q4 2025
Mar 6, 2026
Q3 2025
Nov 12, 2025